News

VIB scientists develop diagnostic tool for Familial Mediterranean Fever
24 November 2016
Researchers at VIB and Ghent University have developed a tool to diagnose Familial Mediterranean Fever (FMF). Particularly common among Mediterranean populations, this genetic disease is characterized by inflammation, fever and severe pain.
VIB-KU Leuven scientists discover neuron-producing stem cells in the membranes covering the brain
23 November 2016
In a cross-domain study directed by professor Peter Carmeliet (VIB – KU Leuven), researchers discovered unexpected cells in the protective membranes that enclose the brain, the so called meninges.
OSPP: Welcoming open science with open arms
19 November 2016
VIB is a founding member of EU-Life, an alliance of top European life sciences research centers. EU-Life was recently appointed by the European Commission to represent research institutions on its new Open Science Policy Platform.
Restoring flawed tumor vessels could lead to better cancer treatments
17 November 2016
Researchers at VIB and KU Leuven have found a novel way to normalize the dysfunctional blood vessels that are typical for tumors. Those vessels play a pivotal role in cancer metastasis.
Research from the group of Sarah Fendt reveals how succinate dehydrogenase is linked to both tumor and neurodegeneration
15 November 2016
Sarah-Maria Fendt (VIB-KU Leuven): “In this project we have studied mutations in the enzyme succinate dehydrogenase, which are associated with tumors, but also neurodegeneration.
Quickscan articles
12 November 2016
Quickscan scientific publications
Neat1 and SAMMSON: similar, yet different anti-cancer targets
12 November 2016
A team of researchers led by Chris Marine (VIB-KU Leuven) has shown that NEAT1, a long non-coding RNA, plays an important role in the survival of highly dividing cells – cancer cells in particular.
Catching a tumor in a spider’s web
10 November 2016
After a decade of research, the Belgian Switch Laboratory (VIB/KU Leuven) has revealed a new designer molecule that inhibits a well-validated cancer driver through the mechanism of amyloid formation.
Researchers reveal how neurodegenerative diseases spread through the brain
9 November 2016
Synapses play a pivotal role in the transmission of toxic proteins. This allows neurodegenerative diseases such as Alzheimer’s to spread through the brain. This the main conclusion of new research led by Patrik Verstreken (VIB-KU Leuven).
Behavior of Alzheimer-linked protein is revealed
8 November 2016
A group of scientists from VIB, VUB and ULB led by Tom Lenaerts (VUB-ULB) and Nico van Nuland (VIB-VUB) uncovered a new mechanism for controlling the activation of a kinase implicated in Alzheimer’s disease
Researchers unravel viruses’ strategies to dodge immune systems
7 November 2016
Researchers led by Savvas Savvides (VIB-UGent) gained surprising insights into how viruses use proteins to inactivate the immune systems of their hosts.
Talking protein tags, novel ideas and tech innovation
5 November 2016
As one of our Expert Scientists, Sven Eyckerman knows all about the ‘tech’ in ‘biotechnology’. Together with his VIB-Ghent University research team, he has been working on several innovative biotechnologies.
UCL/VIB research shows that anti mycoticum fights Staphylococcus aureus
3 November 2016
Françoise Van Bambeke’s teams from the Louvain Drug Research Institute of UCL and Patrick Van Dijck’s teams from VIB and KU Leuven are opening up a new path in treating serious infections which affect patients in hospital.
Controlling plant regeneration systems may drive the future of agriculture
2 November 2016
Belgian scientists from VIB and Ghent University discovered a key protein complex that controls plant tissue repair. Understanding this mechanism is of great agricultural importance
Multidisciplinary approach for groundbreaking study on tumor epigenetics
29 October 2016
A group of researchers lead by Diether Lambrechts (VIB-KU Leuven) explored the mechanisms that cause increased levels of methylation in tumor genes — information that is vital to the adaptation of therapies to fight different types of tumors.

«Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 Next»

Get news updates:

Email updates
Follow us on Twitter
Like us on Facebook
RSS